Sep 03, 2024
1:12
For every 12 shares held, investors received 1.
The split itself did not change the total investment value.
Oruka Therapeutics, Inc. (STU:HQ1) operates in the Pharmaceuticals: major industry.
Oruka Therapeutics, Inc. company overviewOruka Therapeutics, Inc.'s most recent stock split was on September 3, 2024. It was a 1-for-12 reverse split, so shareholders received 1 share for every 12 they held.
Oruka Therapeutics, Inc. (STU:HQ1) has split its stock 6 times: a 1-for-3 reverse split on February 23, 2004, a 1-for-20 reverse split on January 28, 2009, a 1-for-6 reverse split on March 5, 2013, a 1-for-7 reverse split on September 4, 2015, a 1-for-18 reverse split on April 4, 2019, and a 1-for-12 reverse split on September 3, 2024.
Oruka Therapeutics, Inc. has split its stock 6 times. This history records 6 reverse splits between February 23, 2004 and September 3, 2024.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Oruka Therapeutics, Inc.'s 1-for-12 reverse split on September 3, 2024, every 12 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Oruka Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on September 3, 2024, 2 years ago. Companies announce splits in advance, and any new STU:HQ1 split will appear on this page.